..., explaining the link between mechanical dyssynchrony and filling pressure. Conclusion Our combined clinical-computational data demonstrate that in patients with LBBB, the presence of mechanical dyssynchrony indicates relatively normal LV compliance and low filling pressure, which may explain their strong...

...) 14 ± 5 6 ± 2 13 ± 6 9 ± 2 7 ± 3 <0.001  Pulmonary vascular resistance (Wood units) 3.3 (2.5–4.1) 1.3 (0.9–1.7) 2.6 (2.2–3.1) 1.7 (1.6–1.8) 1.4 (1.0–1.8)  Pulmonary artery compliance (mL/mmHg) 1.8 ± 0.8 3.2 ± 1.3 3.1 ± 1.1 3.7 ± 1.0 4.4 ± 2.1 <0.001  Left ventricular...

... recommend screening individuals at increased risk of stroke. This report evaluated the digital recruitment procedure and compliance with the follow-up recommendations in participants with screen-detected AF in the Norwegian Atrial Fibrillation self-screening pilot study. Methods and results Norwegians...

... Aims To understand the compliance, influencing factors, and action path of family cardiac rehabilitation exercise prescriptions for children after congenital heart disease surgery. Methods and results A random sampling method was used to select 200 paediatric patients and their parents from...

... atrial compliance Left atrial fibrosis Inter-atrial shunt Case report Learning points In patients with stiff left atrial (LA) syndrome, reservoir function is significantly impaired due to extensive LA fibrosis, easily leading to pulmonary venous hypertension and subsequent pulmonary congestion...

...-identified US patients who received either SM-RM or BM-RM capable of implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators (Abbott, USA). Patients in SM-RM and BM-RM groups were propensity-score matched on age and gender, device type, implant year, and month. Compliance...

... vascular function. Conclusion In conclusion, we have shown a role for PHACTR1 in arterial compliance across multiple vascular beds. Our study suggests that PHACTR1 has a key structural role within the vasculature. Graphical Abstract Graphical abstract PHACTR1 Compliance...

... factors associated with optimal β-blocker adherence. Pharmacotherapy cLQTS Compliance Arrhythmia Epidemiology Treatment with β-adrenergic receptor antagonists (β-blockers) represents a cornerstone in the management of patients with a clinical diagnosis of congenital long QT syndrome (cLQTS), where...

... permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] Tissue oxygen delivery Venous compliance Venoconstrictor tone Cardiac output Tissue oxygen consumption Auto...

...Casper Binding; Jonas Bjerring Olesen; Christina Ji-Young Lee; Gregory Y H Lip; Caroline Sindet-Pedersen; Gunnar Gislason; Anders Nissen Bonde The term ‘compliance’ refers to the action of accordingly complying to treatment recommendations, while the term ‘adherence’ is closely related...

... and participation, as well as adherence and compliance with programmes, in a contemporary cohort of elderly patients (≥65 years) from eight European centres participating in the EU-CaRE project. 08 06 2020 28 06 2020 10 10 2020 03 10 2020 Published on behalf of the European Society of Cardiology...

... in pretreated patients). Discharge prescription was in compliance with the algorithm in 204 (76%) patients. Average LDL-c at two months was 57 ± 28 mg/dL; it was <55 mg/dL in 135 (50%), and 178 (66%) achieved a >50% reduction. Overall, 125/270 (46%) achieved the LDL-c goal. The reduction in LDL-c observed...

... and safety but also compliance and acceptability. Methods and results  Across 88 French centres, the WEARIT-France study enrolled retrospectively patients who used the WCD between May 2014 and December 2016, and prospectively all patients equipped for WCD therapy between January 2017 and March 2018. All...

... compliance HMG-CoA reductase inhibitors intelligence psychometric g Myocardial infarction (MI) is the most common acute cardiac event, annually affecting around seven million people globally. MI is a consequence of underlying coronary heart disease, the leading cause of death worldwide. ^{1 , 2}...

... survival after an amputation in patients with T2D and LEAD is less than 50%. ² Compliance with recommendations for lifestyle changes and medication is essential for secondary prevention of major adverse cardiovascular events (MACE). In many cases, a cluster of cardiovascular risk factors...

... of these drugs and more often discontinue treatment. Myocardial infarction chronic kidney disease adherence persistence compliance Patients with acute coronary syndrome (ACS) have a high risk of recurrent events, and this risk is significantly higher in patients with concurrent renal dysfunction. ^{1 , 2}...

... medication adherence in a CHD population, as they would be easier to replicate in different settings and on a large scale. Medication adherence medication compliance coronary disease multiple medications polypharmacy systematic review meta-analysis randomised controlled trial Medication adherence...

... and with increasing duration from an acute cardiovascular event. Cardiovascular disease cholesterol-lowering drug therapy blood pressure drug therapy medication compliance Table 2. Use of cholesterol- and BP-lowering drugs among participants with history of cardiovascular disease in SHARE (N = 21,388...

...Sabine JAM Denissen; Carlijn M van der Aalst; Marleen Vonder; Matthijs Oudkerk; Harry J de Koning Cardiovascular disease coronary disease health knowledge attitudes practice mass screening randomised controlled trial treatment adherence and compliance Table 1. Study population...

... Windecker; Adnan Kastrati; Antonio Colombo; Fausto Feres; Peter Jüni; Gregg W Stone; Deepak L Bhatt; Roxana Mehran; Jan G P Tijssen Adherence Compliance Persistence Clinical trial Medication NIH 10.13039/100000002 Corresponding author. Tel: +41 31 632 96 53, Fax: +41 31 632 47 71, Email...